Q32 Bio (QTTB) Institutional Ownership

$42.82

-2.99 (-6.53%)

(As of 09/6/2024 ET)

Current Institutional Ownership Percentage: 31.32%
Number of Institutional Buyers (last 12 months): 15
Total Institutional Inflows (last 12 months): $75.60M

Number of Institutional Sellers (last 12 months): 0

Get QTTB Insider Trade Alerts

Want to know when executives and insiders are buying or selling Q32 Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

QTTB Institutional Buying and Selling by Quarter

Ad Porter & Company

Trump’s weapon lurks in abandoned America

Unemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. Hopelessness abounds. And looking in, the future here looks bleak for these forgotten souls. But in a strange twist of fate, something miraculous is taking place…

Go here now to watch my new documentary

Q32 Bio Major Shareholders & Ownership History

Export to Excel

Reporting Date	Major Shareholder Name	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/13/2024	Ensign Peak Advisors Inc	64,481	$1.16M	0.0%	+150.6%	0.540%
8/9/2024	Renaissance Technologies LLC	14,764	$265K	0.0%	N/A	0.124%
8/9/2024	Harvard Management Co. Inc.	162,965	$2.93M	0.2%	N/A	1.365%
8/1/2024	Rhumbline Advisers	7,658	$137K	0.0%	+11,681.5%	0.064%
7/26/2024	Bank of New York Mellon Corp	17,569	$315K	0.0%	N/A	0.147%
5/17/2024	Ikarian Capital LLC	22,335	$381K	0.0%	N/A	0.685%
5/15/2024	ARCH Venture Management LLC	320,482	$5.46M	6.5%	N/A	9.831%
5/15/2024	Affinity Asset Advisors LLC	27,777	$473K	0.1%	N/A	0.852%
5/14/2024	Platinum Investment Management Ltd.	109,964	$1.87M	0.1%	N/A	3.373%
5/10/2024	Acadian Asset Management LLC	3,695	$62K	0.0%	N/A	0.113%
5/10/2024	Vanguard Group Inc.	107,752	$1.84M	0.0%	N/A	3.305%
5/6/2024	Atlas Venture Life Science Advisors LLC	2,092,106	$35.65M	3.3%	N/A	64.254%
5/3/2024	Carlyle Group Inc.	1,102,741	$18.07M	1.1%	N/A	33.826%
4/23/2024	BML Capital Management LLC	24,894	$424K	0.3%	N/A	0.764%
4/22/2024	Vivo Capital LLC	370,068	$6.31M	0.5%	N/A	11.366%

(Data available from 1/1/2016 forward)

QTTB Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of QTTB shares?: During the previous two years, 15 institutional investors and hedge funds held shares of Q32 Bio. The most heavily invested institutionals were Atlas Venture Life Science Advisors LLC ($35.65M), Carlyle Group Inc. ($18.07M), Vivo Capital LLC ($6.31M), ARCH Venture Management LLC ($5.46M), Harvard Management Co. Inc. ($2.93M), Platinum Investment Management Ltd. ($1.87M), and Vanguard Group Inc. ($1.84M).Learn more on QTTB's institutional investors.
What percentage of Q32 Bio stock is owned by institutional investors?: 31.32% of Q32 Bio stock is owned by institutional investors. Learn more on QTTB's institutional investor holdings.
Which institutional investors have been buying Q32 Bio stock?: Of the 15 institutional investors that purchased Q32 Bio stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Atlas Venture Life Science Advisors LLC ($2.09M), Carlyle Group Inc. ($1.10M), Vivo Capital LLC ($370.07K), ARCH Venture Management LLC ($320.48K), Harvard Management Co. Inc. ($162.97K), Platinum Investment Management Ltd. ($109.96K), and Vanguard Group Inc. ($107.75K).

How much institutional buying is happening at Q32 Bio?: Institutional investors have bought a total of 4,423,455 shares in the last 24 months. This purchase volume represents approximately $75.60M in transactions.

Related Companies: